髂动脉分叉覆膜支架腔内重建技术的初步经验
单中心回顾性分析2022年12月至2023年9月因腹主动脉瘤或既往EVAR失败行EVAR的16例患者共20例次CERIB技术,技术成功率100%,1个月通畅率100%(20/20),无死亡或再干预,结论认为该技术在早期似乎有效安全,需更长随访。
要点
- CERIB技术用于EVAR远端锚定区,在保留髂内动脉血流的同时覆盖髂动脉分叉。
- 16例患者共20例次CERIB,技术成功率100%,无辅助操作。
- 术后30天无死亡或再干预,1个月CTA通畅率100%(20/20)。
核心结论
- CERIB技术在早期似乎有效且安全,适用于多种商业腔内移植物平台。
- 当存在解剖学考量时,它可能是髂动脉分支装置的有价值替代方案。
- 需要更长的随访来确定长期通畅性和耐久性。
研究设计与样本
- 单中心、回顾性分析前瞻性收集的数据,纳入2022年12月至2023年9月因完整腹主动脉瘤或既往EVAR失败行EVAR的患者。
- 治疗指征为存在髂总动脉瘤、短髂总动脉或Ib型内漏。
- 远端密封区使用球囊扩张式覆膜支架(BXCS)。
- 主要结局为技术成功和第一个月通畅率,次要结局为内漏和再干预率。
主要发现
- 共纳入16例患者,接受20例次CERIB技术。
- 4例患者为既往EVAR失败,3例患者因症状性肾旁动脉瘤紧急治疗。
- 治疗指征为EIb(n=2)、短髂总动脉(n=4)、窄腔髂总动脉瘤(n=3)和髂总动脉瘤(n=11)。
- 使用的平台包括Cook Zenith Alpha(n=5)、Gore C3(n=2及3条分支)、Endurant IIs(n=2及3条分支)和t-branch装置(n=3)。
- 技术成功率为100%,无辅助操作;术后30天所有患者及2例患者术后6个月无死亡或再干预记录。
临床怎么用
- 作者认为CERIB技术在早期似乎有效且安全,适用于多种商业腔内移植物平台。
- 作者认为当存在解剖学考量时,它可能是髂动脉分支装置的有价值替代方案。
- 作者指出需要更长的随访来确定长期通畅性和耐久性。
局限性
- 原文指出需要更长的随访来确定长期通畅性和耐久性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The distal landing zone in iliac arteries represents an important issue during endovascular repair of abdominal aortic aneurysms (EVAR). The aim of this study is to present a case series for landing in the external iliac artery (EIA) during EVAR while preserving blood flow in the internal iliac artery (IIA) with the covered endovascular reconstruction of the iliac bifurcation (CERIB) technique. METHODS: This is a single-center, retrospective analysis of prospectively collected data of patients that underwent EVAR either for intact abdominal aortic aneurysm (AAA) or previous failed EVAR from December 2022 up to September 2023. Indications for treatment were presence of common iliac artery aneurysm (CIAA), short CIA, or endoleak type Ib (ETIb). For the distal sealing zone, we used balloon-expandable covered stent (BXCS). Primary outcomes were technical success and first-month patency rate. Secondary outcomes were endoleak and re-intervention rate. RESULTS: Sixteen patients being treated with 20 CERIBs were included in the study. Four patients had a previous failed EVAR, while 3 patients were treated urgently for a symptomatic para-renal aneurysm. The indications for treatment were EIb (n=2), short CIA (n=4), CIAA with narrow lumen (n=3), and CIA aneurysm (n=11). Platforms that were used were the Cook Zenith Alpha (n=5), Gore C3 (n=2 and 3 limbs), Endurant IIs (n=2, and 3 limbs), and a t-branch device (n=3). Technical success rate was 100% with no adjunctive procedure. No death or re-intervention was recorded for all patients at postoperative 30-day period and at 6 months for 2 patients. At first-month CTA, patency rate was 100% (20/20), while in 2 patients that had 6-month CTA, the patency was also 100% (2/2). No kinking or stenosis was also noted. Two patients had ETIII after branched EVAR (BEVAR), 2 patients had ETII, and 1 patient had gutter ET in the area of the CERIB. CONCLUSION: The CERIB technique seems to be effective and safe in the early period. It is suitable with a variety of commercial endograft platforms. It may be a valuable alternative to iliac branch devices when there are anatomical considerations. Longer follow-up is needed to conclude for long-term patency and durability.Clinical ImpactThe distal landing zone in iliac arteries represents an important issue during EVAR while it is important to preserve blood flow in the internal iliac artery. The covered endovascular reconstruction of the iliac bifurcation (CERIB) technique is a technique for the preservation of internal iliac arteries during EVAR, while it is suitable with a variety of commercial endograft platforms. The CERIB technique seems to be effective and safe in the early period. It may be valuable alternative to iliac branch devices when there are anatomical considerations.
引用
- Matsagkas M, Spanos K, Haidoulis A, et al. Initial Experience of the Covered Endovascular Reconstruction of Iliac Bifurcation Technique. J Endovasc Ther. 2024. PMID: 38813976. doi:10.1177/15266028241256507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。